Salient Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-7,750
| Closed | -$432K | – | 74 |
|
|
2017
Q2 | $432K | Sell |
7,750
-65
| -0.8% | -$3.62K | 0.01% | 161 |
|
|
2017
Q1 | $425K | Buy |
7,815
+450
| +6% | +$24.5K | 0.01% | 194 |
|
|
2016
Q4 | $430K | Sell |
7,365
-847
| -10% | -$49.5K | 0.01% | 191 |
|
|
2016
Q3 | $443K | Buy |
8,212
+252
| +3% | +$13.6K | 0.01% | 171 |
|
|
2016
Q2 | $585K | Sell |
7,960
-173
| -2% | -$12.7K | 0.01% | 159 |
|
|
2016
Q1 | $520K | Sell |
8,133
-3,640
| -31% | -$233K | 0.01% | 168 |
|
|
2015
Q4 | $810K | Sell |
11,773
-1,690
| -13% | -$116K | 0.02% | 134 |
|
|
2015
Q3 | $797K | Sell |
13,463
-607
| -4% | -$35.9K | 0.02% | 142 |
|
|
2015
Q2 | $936K | Sell |
14,070
-20
| -0.1% | -$1.33K | 0.02% | 145 |
|
|
2015
Q1 | $909K | Sell |
14,090
-1,040
| -7% | -$67.1K | 0.02% | 142 |
|
|
2014
Q4 | $893K | Buy |
15,130
+1,548
| +11% | +$91.4K | 0.02% | 160 |
|
|
2014
Q3 | $695K | Sell |
13,582
-223
| -2% | -$11.4K | 0.01% | 164 |
|
|
2014
Q2 | $670K | Sell |
13,805
-520
| -4% | -$25.2K | 0.01% | 159 |
|
|
2014
Q1 | $744K | Sell |
14,325
-24,970
| -64% | -$1.3M | 0.02% | 154 |
|
|
2013
Q4 | $2.09M | Buy |
39,295
+320
| +0.8% | +$17K | 0.07% | 88 |
|
|
2013
Q3 | $1.8M | Buy |
38,975
+1,222
| +3% | +$56.6K | 0.08% | 85 |
|
|
2013
Q2 | $1.69M | Buy |
+37,753
| New | +$1.69M | 0.08% | 84 |
|